Heart Institute Research

badge 1

Le Bonheur's Heart Institute is at the forefront of research for children with a variety of heart conditions including the latest methods of PDA closure, cardio-oncology and the effects of chemotherapy on the heart and the genetic factors of cardiomyopathy. We are committed to finding the latest therapies and breakthroughs for children with congenital heart defects.

heart research

 

Our Research

  • Outcomes in children with left ventricular (LV) noncompaction
  • Mitral valve function in LV noncompaction
  • Electrophysiological aspects of LV noncompaction
  • Genetic and mechanistic basis of LV noncompaction
  • Genetic and mechanistic basis of arrhythmogenic cardiomyopathies
  • Electrophysiological aspects of arrhythmogenic cardiomyopathies: molecular basis
  • Renal function monitoring in heart transplant patients: Is cystatin C a better biomarker than creatinine?
  • The role of viral genome in the heart of transplant patients and rejection and coronary vasculopathy
  • Discovery of common biomarkers in cardiac and skeletal myopathy

 

Clinical Trials

If you are interested in participating in a cardiology clinical trial, please view our list of current and active trials.

 

Recent Publications

Related Articles

publication issue image
Le Bonheur enrolls first patient in the country in multi-center PREEMIE trial

Study evaluates the safety and efficacy of the Bloom™ Micro Occluder System....

publication issue image
First patient in US enrolled in VALOR clinical trial

Principal Investigator Jeffrey A. Towbin, MD, co-executive director of Le Bonheur’s Heart Institute,...

publication issue image
Consensus Care Model for HCM

Le Bonheur Heart Institute Co-Executive Director publishes new guidelines for diagnosis, evaluation ...

publication issue image
Beating Hearts, Beating Cancer

Association of persistent tachycardia with early myocardial dysfunction in children undergoing allog...

Contact Heart Institute